To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
Clinical trial NCT03655210 · COMPLETED
Trial details
- NCT number
- NCT03655210
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-07
- Primary completion
- 2017-02-20
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.